Ciltacabtagene Autoleucel Clinical Trials
4 recruitingBiologic
Phase 12Phase 21
Showing 1–4 of 4 trials
Recruiting
Phase 1
Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function
Multiple Myeloma
Washington University School of Medicine16 enrolled1 locationNCT06623630
Recruiting
Phase 2
Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
Refractory Multiple MyelomaRecurrent Multiple Myeloma
Mayo Clinic44 enrolled1 locationNCT06940297
Recruiting
Phase 1
Cilta-Talq Fusion Study: A Phase 1b Study of Talquetamab Bridging Therapy Followed by Ciltacabtagene Autoleucel in Patients With Relapsed/Refractory Multiple Myeloma
Refractory Multiple MyelomaRelapse Multiple Myeloma
Medical College of Wisconsin31 enrolled1 locationNCT07093554
Recruiting
The Norwegian Immunotherapy in Multiple Myeloma Study
St. Olavs Hospital400 enrolled23 locationsNCT06855121